Abraxane (albumin-bound paclitaxel)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Abraxane (albumin-bound paclitaxel), covering 2024-07-19 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma [Phase 1, Phase 2]